Exponent (NASDAQ:EXPO) (NASDAQ: EXPO) is a global multi-disciplinary engineering and scientific consulting firm that provides a wide range of services to industry and government clients. The company applies expertise in fields such as materials science, structural engineering, environmental health, and computational science to investigate product failures, assess environmental and health risks, and support regulatory compliance. Exponent’s integrated approach combines laboratory testing, forensic analysis, and advanced modeling techniques to address complex technical challenges across diverse sectors.
Serving clients in aerospace, automotive, energy, healthcare, consumer products, and manufacturing, Exponent delivers services that include accident reconstruction, human health risk assessment, exposure assessment, and environmental due diligence. The firm’s laboratories are equipped for chemical analysis, biomechanics, polymers testing, and fire safety evaluation, while its field teams conduct site investigations and data collection worldwide. Exponent maintains offices and laboratory facilities across North America, Europe, Asia, and the Middle East, enabling it to support multinational projects and respond to local regulatory requirements.
Founded in 1967 as Failure Analysis Associates by Dr. Brian T. O’Neill, the company has evolved from a small technical consultancy into a publicly traded corporation with a global footprint. Through strategic acquisitions and organic growth, Exponent has expanded its scientific disciplines and geographic reach. Since 2013, Paul P. Schoeppner has served as President and Chief Executive Officer, guiding the firm’s commitment to technical excellence, client service, and innovation in engineering and scientific problem-solving.
